BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1822 related articles for article (PubMed ID: 30707967)

  • 1. Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35-37 weeks' gestation.
    Ciobanu A; Rouvali A; Syngelaki A; Akolekar R; Nicolaides KH
    Am J Obstet Gynecol; 2019 May; 220(5):486.e1-486.e11. PubMed ID: 30707967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.
    Bakalis S; Peeva G; Gonzalez R; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):446-51. PubMed ID: 25826154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Ciobanou A; Jabak S; De Castro H; Frei L; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jul; 54(1):79-86. PubMed ID: 31100188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):203-9. PubMed ID: 26224608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-stage approach for prediction of small-for-gestational-age neonate and adverse perinatal outcome by routine ultrasound examination at 35-37 weeks' gestation.
    Akolekar R; Panaitescu AM; Ciobanu A; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):484-491. PubMed ID: 31271475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of small-for-gestational-age neonates: screening by placental growth factor and soluble fms-like tyrosine kinase-1 at 35-37 weeks.
    Fadigas C; Peeva G; Mendez O; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Aug; 46(2):191-7. PubMed ID: 25825848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine assessment of cerebroplacental ratio at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Akolekar R; Ciobanu A; Zingler E; Syngelaki A; Nicolaides KH
    Am J Obstet Gynecol; 2019 Jul; 221(1):65.e1-65.e18. PubMed ID: 30878322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of small-for-gestational-age neonates at 35-37 weeks' gestation: contribution of maternal factors and growth velocity between 32 and 36 weeks.
    Ciobanu A; Anthoulakis C; Syngelaki A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 May; 53(5):630-637. PubMed ID: 30912210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 35-37 weeks.
    Fadigas C; Guerra L; Garcia-Tizon Larroca S; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Jun; 45(6):715-21. PubMed ID: 25780898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ophthalmic artery Doppler and biomarkers of impaired placentation at 36 weeks' gestation in pregnancies with small fetuses.
    Arechvo A; Wright A; Nobile Recalde A; Liandro R; Charakida M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2024 Mar; 63(3):358-364. PubMed ID: 37902727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-trimester contingent screening for small-for-gestational-age neonate.
    Nowacka U; Papastefanou I; Bouariu A; Syngelaki A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):177-184. PubMed ID: 34214232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competing-risks model for prediction of small-for-gestational-age neonate at 36 weeks' gestation.
    Papastefanou I; Thanopoulou V; Dimopoulou S; Syngelaki A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2022 Nov; 60(5):612-619. PubMed ID: 36056735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 19-24 weeks.
    Poon LC; Lesmes C; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):437-45. PubMed ID: 25988293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34 weeks.
    Bakalis S; Gallo DM; Mendez O; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Aug; 46(2):208-15. PubMed ID: 25826797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 30-34 weeks.
    Bakalis S; Stoilov B; Akolekar R; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Jun; 45(6):707-14. PubMed ID: 25585604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of small-for-gestational-age neonates at 35-37 weeks' gestation: contribution of maternal factors and growth velocity between 20 and 36 weeks.
    Ciobanu A; Formuso C; Syngelaki A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Apr; 53(4):488-495. PubMed ID: 30779239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of angiogenic factors in prediction of growth-related neonatal morbidity at term and comparison with competing-risks model.
    Papastefanou I; Nobile Recalde A; Silva Souza Y; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2024 Apr; 63(4):457-465. PubMed ID: 37963283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 19-24 weeks.
    Lesmes C; Gallo DM; Saiid Y; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Sep; 46(3):332-40. PubMed ID: 25810352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of competing-risks model with angiogenic factors in midgestation screening for preterm growth-related neonatal morbidity.
    Papastefanou I; Menenez M; Szczepkowska A; Gungil B; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2024 May; 63(5):613-618. PubMed ID: 38057964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 92.